ICON is pleased to once again be the global clinical research sponsor for the Financial Times US Pharma and Biotech Summit, May 16, 2024, in New York. 

The event will feature biopharma leaders, regulators, investors and scientists discussing some of the important trends affecting our industry, including:

• Key macro-economic issues impacting investing in innovation
• How artificial intelligence is being applied in clinical development, and 
• The ongoing and evolving focus on patient-centricity

As a lead sponsor, ICON is pleased to offer a limited number of in-person and digital registrations our customers and others to this premier event. 

• Alex Kalomparis, Senior Vice President, Public Affairs, Gilead Sciences
• Alissa Brown, Head of Organizational Capability and Transformation, Sanofi
• Amy West, Head of US Digital Transformation and Innovation, Novo Nordisk
• Bari Kowal, SVP, Regeneron
• Belen Fraile, Global Head of Data and Digital, Moderna
• Christopher Viehbacher, President and CEO, Biogen
• Cindy Perettie, Executive VP and Global Head, Kite, a Gilead Company
• Debra Jennings, Head of Transformation and Operations, Takeda Oncology
• Doug Danison, Head of Commercial, Cell and Gene Therapy Unit, Bayer
• Eden Wells, Chief Patient Experience Officer, Novartis
• James Sabry, Global Head, Pharma Partnering, Roche
• Ken Keller, Chairman, President and CEO, Daiichi Sankyo, Inc.
• Robert Truckenmiller, SVP, Head of US Vaccines, GSK
• Roger Perlmutter, CEO, Eikon Therapeutics
• Tadaaki Taniguchi, Chief Medical Officer, Astellas Pharma
• Terri Stewart, Head Global Healthcare Govt and Public Affairs, EMD Serono
• Tom Miller, Co-Founder and CEO, Iambic Therapeutics
• Zachariah Reitano, CEO and Co-founder, Ro 

See the full agenda at US Pharma and Biotech Summit 2024 Agenda - A FTLive Event.